CLEMENTIA PHARMACEUTICALS
Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. The company develops disease-modifying treatments for patients suffering from debilitating bone and other diseases with a high unmet medical need. The company's lead product candidate, palovarotene, is an oral small molecule that has shown potent activity in preventing abnormal new bone formation as well as fibrosis in a variety of tissues. Clementia Pharmaceuticals was founded in 2012 and is headquartered in Montréal, Quebec.
CLEMENTIA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
2010-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.ipsen.com
Total Employee:
11+
Status:
Active
Contact:
(514) 940-3600
Total Funding:
92.5 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS BootstrapCDN Amazon Route 53 Sectigo SSL
Similar Organizations
Abwiz Bio
We provide researchers world-wide with top-quality monoclonal antibodies
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
AlgaeCytes
AlgaeCytes uses a photobioreactor system and freshwater algal strains to produce high purity Omega 3 oils EPA.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Axol Bioscience
Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.
BioFeyn
BioFeyn is enhancing the efficiency and sustainability of marine ingredients for use in aquaculture.
BrainXell
BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
ClostraBio
ClostraBio is a provider of a bio pharma company intended to develop therapeutics for food allergies.
Ella Biomedical
Ella is bringing mindfulness programs online to manage your pain.
Foresite Labs
Foresite Labs is a biotechnology company.
Genoa Pharmaceuticals
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Genome Profiling
Genome Profiling company focused on epigenetic biomarker discovery.
IDP Pharma
IDP Pharma is a first in class drug for multiple mieloma treatment, to set up new discovery programs.
InVivo
InVivo helps agriculture cooperation regain their rightful place in the global food value chain.
Jennerex Biotherapeutics
Jennerex is a clinical-stage biopharmaceutical company developing targeted oncolytic products for the treatment of cancer.
Joekai
Joekai is a specialty contract research organization that focuses on biological services in the area of CNS disorders.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
LiveLeaf
LiveLeaf develops therapeutic products designed to turn the biochemistry of plant immunity into sustainable one.
Naurex
Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Nortis
Nortis is developing the next generation of invitro systems that will allow scientists to better understand the causes of human diseases.
Oisin Biotechnologies
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Profacgen
Profacgen is a state-of-the-art protein service provider.
ResQ Pharma
ResQ Pharma is a research & development company that develops drugs and therapies for treating lipophilic drug overdoses and poisonings.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Seraph Biosciences
Seraph Biosciences is a developer of real-time pathogen detection systems used to treat infections.
Solaris Farm
High-Tech Hybrid Cannabis Greenhouse
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Spinnaker Biosciences
Spinnaker Biosciences specializes in offering ophthalmic drug delivery technologies.
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Larimar Therapeutics
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Clarissa Desjardins CEO @ Clementia Pharmaceuticals
CEO
2013-04-01
Michael Singer Chief Financial Officer @ Clementia Pharmaceuticals
Chief Financial Officer
Founder
Stock Details
Investors List
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Clementia Pharmaceuticals
BDC Healthcare Venture
BDC Healthcare Venture investment in Venture Round - Clementia Pharmaceuticals
RA Capital Management
RA Capital Management investment in Venture Round - Clementia Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Venture Round - Clementia Pharmaceuticals
UCB
UCB investment in Venture Round - Clementia Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Clementia Pharmaceuticals
OrbiMed
OrbiMed investment in Venture Round - Clementia Pharmaceuticals
Janus Capital Group
Janus Capital Group investment in Venture Round - Clementia Pharmaceuticals
BDC Healthcare Venture
BDC Healthcare Venture investment in Series A - Clementia Pharmaceuticals
OrbiMed
OrbiMed investment in Series A - Clementia Pharmaceuticals
Newest Events participated
Participated in 14th Annual International Pediatric Orthopaedic Symposium
on 2017-11-28 as sponsor
Official Site Inspections
http://www.ipsen.com
- Host name: server-3-167-112-97.iad55.r.cloudfront.net
- IP address: 3.167.112.97
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Clementia Pharmaceuticals"
Ipsen - Wikipedia
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases …See details»
Ipsen - The Org
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - …See details»
About - Ipsen US
Through our charitable contribution efforts, Ipsen provides donations to 501 (c)(3) organizations located in the US that are aligned with our company social responsibility priorities and focus on …See details»
Ipsen - Crunchbase Company Profile & Funding
Ipsen invests in R&D to advance scientific discovery and develop new therapeutic solutions across its focus areas. Clinical Trials: Ipsen conducts clinical trials to evaluate the safety and …See details»
About - Ipsen Global
Today, the manufacturing facility is the world’s largest producer of vacuum furnace hot zones. Ipsen introduces Global VR, a TurboTreater unit with convection, the AvaC furnace and the TITAN furnace, a compact, global …See details»
Ipsen Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 Ipsen is a global specialty-driven biotechnological group with total sales exceeding €1.2 billion in 2014 in more than 115 countries, with a direct commercial presence in 30 …See details»
About Ipsen | Pioneering Biopharmaceutical Company
In 1983, the group created the Fondation Ipsen under the aegis of the Fondation de France, to encourage exchanges between scientists in the field of life sciences. In 1986, the group launched Decapeptyl ®, used to treat certain …See details»
Ipsen Org Chart + Executive Team - The Official Board
The org chart of Ipsen contains its 72 main executives like David Loew, Aymeric Le Chatelier and Sandra Silvestri.See details»
Choose your country - Ipsen Academy
Ipsen Farmaceutica B.V. Taurusavenue 33b 2132 LS Hoofddorp Nederland Ipsen Group Ipsen NV/SA Guldensporenpark 87 9820 Merelbeke Belgium You are about to leave The Academy …See details»
Ipsen: a dynamic, fast-growing specialty care …
Ipsen is the first company to test recombinant toxins in preclinical and phase 1 clinical studies 4; the strong internal expertise of its R&D teams has played a critical role in the establishment ...See details»
GMA Onboarding - MASA Team - Global
The MASA team works across the Medical organization to support change management, to ensure adoption and consistent application across countries, and to offer solutions to optimize …See details»
Ipsen: who we are - United States
Laboratoires Beaufour created a subsidiary, Ipsen, in 1975, and began to internationalize its activities. In 1976, the company opened a research center in Hopkinton (Massachusetts) in the …See details»
Ipsen Executive Management | Leading Innovation and Growth
Ipsen’s Executive Leadership Team is composed of the Chief Executive Officer and 13 executive members. David Loew . Chief Executive Officer . Bartek Bednarz . Executive Vice President . …See details»
Corporate social responsibility | Ipsen Global
We are proud to announce that Ipsen’s rating has reached an all-time high in the 2024 S&P Global Corporate Sustainability Assessment (CSA). Our score has increased by 4 points, from …See details»
Ipsen Global - Un groupe biopharmaceutique | Innover pour les …
May 7, 2025 Chez Ipsen, notre mission commune nous nous guide vers la construction d’un avenir plus sain et plus résilient pour les personnes et la planète. A travers notre stratégie de …See details»
People at Ipsen | Fostering a Diverse & Inclusive Workplace - Global
Ipsen is committed to promoting gender balance at all levels of our organization. In 2024, 46,2% of our Executive Leadership team and 57,2% of our Global Leadership team are women. A …See details»
Hello Ipsen - Innovation for patient care
Innovation for patient care. Les patients et la société s’inscrivent au cœur de notre mission. Nous atteignons notre objectif d’améliorer la vie des patients et leur état de santé grâce à une …See details»
Explore IPSEN CARES® - IpsenCares.ca
To request Medical Information, report an Adverse Event or Product Quality Complaint for Ipsen Canada’s products, please contact Ipsen Canada Medical Information at: Phone: 1-855-215 …See details»
Ipsen receives positive CHMP opinion for Cabometyx® in
1 day ago About Ipsen. We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and …See details»
Ipsen receives positive CHMP opinion for Cabometyx® in …
1 day ago Ipsen must face or might face competition from generic medicine that might translate into a loss of market share. Furthermore, the research and development process involves …See details»